このアイテムのアクセス数: 4
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
s12931-024-03075-8.pdf | 3.04 MB | Adobe PDF | 見る/開く |
タイトル: | Prognostic value of a composite physiologic index developed by adding bronchial and hyperlucent volumes quantified via artificial intelligence technology |
著者: | Uyama, Michihiro Handa, Tomohiro Uozumi, Ryuji Hashimoto, Seishu Taguchi, Yoshio Ikezoe, Kohei ![]() ![]() ![]() Tanizawa, Kiminobu Tanabe, Naoya ![]() ![]() ![]() Oguma, Tsuyoshi Matsunashi, Atsushi Niwamoto, Takafumi Shima, Hiroshi Mori, Ryobu Maetani, Tomoki Shiraishi, Yusuke Nobashi, W, Tomomi Sakamoto, Ryo ![]() ![]() Kubo, Takeshi Yoshizawa, Akihiko Terada, Kazuhiro Nakamoto, Yuji Hirai, Toyohiro |
キーワード: | Artificial intelligence-based quantitative computed tomographic image analysis software Composite physiologic index Idiopathic pulmonary fibrosis Interstitial lung disease Bronchial volume Hyperlucent volume |
発行日: | 24-Dec-2024 |
出版者: | Springer Nature BMC |
誌名: | Respiratory research |
巻: | 25 |
号: | 1 |
論文番号: | 442 |
抄録: | Background: The composite physiologic index (CPI) was developed to estimate the extent of interstitial lung disease (ILD) in idiopathic pulmonary fibrosis (IPF) patients based on pulmonary function tests (PFTs). The CALIPER-revised version of the CPI (CALIPER-CPI) was also developed to estimate the volume fraction of ILD measured by CALIPER, an automated quantitative CT postprocessing software. Recently, artificial intelligence-based quantitative CT image analysis software (AIQCT), which can be used to quantify the bronchial volume separately from the ILD volume, was developed and validated in IPF. The aim of this study was to develop AIQCT-derived CPI formulas to quantify CT abnormalities in IPF and to investigate the associations of these CPI formulas with survival. Methods: The first cohort included 116 patients with IPF. In this cohort, ILD, bronchial, and hyperlucent volumes on CT were quantified using AIQCT. New CPI formulas were developed based on PFTs to estimate the volume fraction of ILD (ILD-CPI), the sum of the ILD and bronchial volume fractions (ILDB-CPI), and the sum of the ILD, bronchial and hyperlucent volume fractions (ILDBH-CPI). The associations of the original CPI, the CALIPER-CPI and the AIQCT-derived CPIs with survival were analyzed in the first cohort and in a second cohort of patients with IPF (n = 72). Results: In the first cohort, over a median observation time of 92.8 months, 79 patients (68.1%) died, and one patient (0.9%) underwent living-donor lung transplantation. The original CPI, the CALIPER-CPI, and all AIQCT-derived CPIs were associated with overall survival (hazard ratios: 1.07–1.22). The C-index of the ILDB-CPI (0.759) was the highest among all AIQCT-derived CPIs and was comparable to that of the original CPI (0.765) and the CALIPER-CPI (0.749). The C-index of the ILDBH-CPI (0.729) was lower than that of the other CPI variables. The second cohort yielded similar C-indices as the first cohort for the original CPI (0.738), CALIPER-CPI (0.757) and ILDB-CPI (0.749). Conclusions: The ILDB-CPI can predict the outcomes of IPF patients with a similar performance to that of the original CPI and the CALIPER-CPI. Adding the hyperlucent volume to the CPI formula did not improve its predictive accuracy for mortality. |
著作権等: | © The Author(s) 2024 This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. |
URI: | http://hdl.handle.net/2433/293126 |
DOI(出版社版): | 10.1186/s12931-024-03075-8 |
PubMed ID: | 39719582 |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス